BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22028922)

  • 21. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
    Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.
    Hu B; Ding GY; Fu PY; Zhu XD; Ji Y; Shi GM; Shen YH; Cai JB; Yang Z; Zhou J; Fan J; Sun HC; Kuang M; Huang C
    J Hematol Oncol; 2018 Feb; 11(1):28. PubMed ID: 29482578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.
    Sun W; Dong WW; Mao LL; Li WM; Cui JT; Xing R; Lu YY
    World J Gastroenterol; 2013 May; 19(19):2913-20. PubMed ID: 23704824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
    Hu B; Yang XB; Yang X; Sang XT
    Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
    You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L
    Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
    Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
    Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
    Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
    Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
    Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.
    Liang Y; Luo H; Zhang H; Dong Y; Bao Y
    Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.